Accelerate Stock Future Price Prediction


USD 0.75  0.08  9.64%   

Accelerate Diagnostics stock price prediction is an act of determining the future value of Accelerate Diagnostics shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Accelerate Diagnostics' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Accelerate Diagnostics and does not consider all of the tangible or intangible factors available from Accelerate Diagnostics' fundamental data. We analyze noise-free headlines and recent hype associated with Accelerate Diagnostics, which may create opportunities for some arbitrage if properly timed.
Please continue to Accelerate Diagnostics Basic Forecasting Models to cross-verify your projections.
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Accelerate Diagnostics based on different types of headlines from major news networks to social media. The Accelerate stock price prediction module provides an analysis of price elasticity to changes in media outlook on Accelerate Diagnostics over a specific investment horizon.
EPS Estimate Next Quarter
EPS Estimate Current Year
EPS Estimate Next Year
Wall Street Target Price
EPS Estimate Current Quarter
Quarterly Revenue Growth YOY
Using Accelerate Diagnostics hype-based prediction, you can estimate the value of Accelerate Diagnostics from the perspective of Accelerate Diagnostics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Accelerate Diagnostics using Accelerate Diagnostics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Accelerate using crowd psychology based on the activity and movement of Accelerate Diagnostics' stock price.
Accelerate Diagnostics Price to Sales Ratio is fairly stable at the moment as compared to the past year. Accelerate Diagnostics reported Price to Sales Ratio of 27.35 in 2021. Sales per Share is likely to rise to 0.21 in 2022, whereas Operating Margin is likely to drop (43.11)  in 2022.

Accelerate Diagnostics Short Interest

A significant increase or decrease in Accelerate Diagnostics' short interest from the previous month could be a good indicator of investor sentiment towards Accelerate. Short interest can provide insight into the potential direction of Accelerate Diagnostics stock and how bullish or bearish investors feel about the market overall. An investor who is long Accelerate Diagnostics may also wish to track short interest. As short interest increases, investors should be becoming more worried about Accelerate Diagnostics and may potentially protect profits, hedge Accelerate Diagnostics with its derivative instruments, or be ready for some potential downside.
200 Day MA
Short Percent
Short Ratio
Shares Short Prior Month
50 Day MA
Shares Short
3.9 M

Accelerate Diagnostics Hype to Price Pattern

Investor biases related to Accelerate Diagnostics' public news can be used to forecast risks associated with investment in Accelerate. The trend in average sentiment can be used to explain how an investor holding Accelerate can time the market purely based on public headlines and social activities around Accelerate Diagnostics. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Accelerate Diagnostics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Accelerate Diagnostics.

Accelerate Diagnostics Implied Volatility

Accelerate Diagnostics' implied volatility exposes the market's sentiment of Accelerate Diagnostics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Accelerate Diagnostics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Accelerate Diagnostics stock will not fluctuate a lot when Accelerate Diagnostics' options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Accelerate Diagnostics. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Accelerate Diagnostics to buy its stock at a price that has no basis in reality. In that case, they are not buying Accelerate because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Accelerate Diagnostics after-hype prediction price

  USD 0.78  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Accelerate Diagnostics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Accelerate Diagnostics in the context of predictive analytics.
LowReal ValueHigh
2 Analysts
LowTarget PriceHigh
Estimates (1)
LowProjected EPSHigh
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Accelerate Diagnostics. Your research has to be compared to or analyzed against Accelerate Diagnostics' peers to derive any actionable benefits. When done correctly, Accelerate Diagnostics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Accelerate Diagnostics.

Accelerate Diagnostics After-Hype Price Prediction Density Analysis

As far as predicting the price of Accelerate Diagnostics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Accelerate Diagnostics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Accelerate Diagnostics, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Accelerate Diagnostics Estimiated After-Hype Price Volatility

In the context of predicting Accelerate Diagnostics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Accelerate Diagnostics' historical news coverage. Accelerate Diagnostics' after-hype downside and upside margins for the prediction period are 0.04 and 8.67, respectively. We have considered Accelerate Diagnostics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value 0.75
After-hype Price
Accelerate Diagnostics is dangerous asset. Analysis and calculation of next after-hype price of Accelerate Diagnostics is based on 3 months time horizon.

Accelerate Diagnostics Stock Price Prediction Analysis

Have you ever been surprised when a price of a company such as Accelerate Diagnostics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Accelerate Diagnostics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Accelerate Diagnostics, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.80  7.89  0.03    0.22  6 Events / Month4 Events / MonthIn about 6 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility

Accelerate Diagnostics Hype Timeline

Accelerate Diagnostics is presently traded for 0.75. The entity has historical hype elasticity of 0.03 and average elasticity to hype of competition of -0.22. Accelerate is forecasted to increase in value after the next headline with the price projected to jump to 0.78 or above. The average volatility of media hype impact on the company stock price is over 100%. The price jump on the next news is forecasted to be 4.0% whereas the daily expected return is presently at -0.8%. The volatility of related hype on Accelerate Diagnostics is about 2863.31% with expected price after next announcement by competition of 0.53. The company currently holds 107.98 M in liabilities with Debt to Equity (D/E) ratio of 2.76, implying the company greatly relies on financing operations through barrowing. Given the investment horizon of 90 days the next forecasted press release will be in about 6 days.
Please continue to Accelerate Diagnostics Basic Forecasting Models to cross-verify your projections.

Accelerate Diagnostics Related Hype Analysis

Having access to credible news sources related to Accelerate Diagnostics' direct competition is more important than ever and may enhance your ability to predict Accelerate Diagnostics' future price movements. Getting to know how Accelerate Diagnostics rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Accelerate Diagnostics may potentially react to the hype associated with one of its peers.
At Risk
ACORAcorda Therapeutics(0.03) 4 per month 8.00  0.09  13.33 (18.89)  189.94 
ACIUAC Immune(0.22) 1 per month 0.00 (0.037)  8.92 (7.34)  35.67 
ACRSAclaris Therapeutics 0.16 3 per month 4.73  0.0124  6.21 (7.06)  21.28 
ABEOAbeona Therapeutics(0.34) 5 per month 6.13  0.0383  12.24 (8.98)  42.59 
ABUSArbutus Biopharma Corp(0.08) 2 per month 3.27  0.0348  5.68 (4.71)  15.91 
ACADACADIA Pharmaceuticals(1.93) 6 per month 0.00 (0.0329)  5.59 (5.64)  18.55 
ACERAcer Therapeutics 0.04 3 per month 3.74  0.033  7.41 (6.61)  16.50 
ACBAurora Cannabis(0.07) 4 per month 0.00 (0.0217)  10.40 (7.41)  26.64 
ACHVAchieve Life Sciences(0.01) 9 per month 0.00 (0.19)  5.29 (6.05)  18.68 

Accelerate Diagnostics Additional Predictive Modules

Most predictive techniques to examine Accelerate price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Accelerate using various technical indicators. When you analyze Accelerate charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Accelerate Diagnostics Predictive Indicators

The successful prediction of Accelerate Diagnostics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Accelerate Diagnostics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Accelerate Diagnostics based on analysis of Accelerate Diagnostics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Accelerate Diagnostics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Accelerate Diagnostics's related companies.
 2021 2022 (projected)
PPandE Turnover2.042.1
Long Term Debt to Equity1.882.03

Story Coverage note for Accelerate Diagnostics

The number of cover stories for Accelerate Diagnostics depends on current market conditions and Accelerate Diagnostics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Accelerate Diagnostics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Accelerate Diagnostics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Accelerate Diagnostics Short Properties

Accelerate Diagnostics' future price predictability will typically decrease when Accelerate Diagnostics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Accelerate Diagnostics often depends not only on the future outlook of the potential Accelerate Diagnostics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Accelerate Diagnostics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding61727000.00
Cash And Short Term Investments63618000.00
Please continue to Accelerate Diagnostics Basic Forecasting Models to cross-verify your projections. Note that the Accelerate Diagnostics information on this page should be used as a complementary analysis to other Accelerate Diagnostics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Complementary Tools for Accelerate Stock analysis

When running Accelerate Diagnostics price analysis, check to measure Accelerate Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Accelerate Diagnostics is operating at the current time. Most of Accelerate Diagnostics' value examination focuses on studying past and present price action to predict the probability of Accelerate Diagnostics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Accelerate Diagnostics' price. Additionally, you may evaluate how the addition of Accelerate Diagnostics to your portfolios can decrease your overall portfolio volatility.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Equity Valuation
Check real value of public entities based on technical and fundamental data
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Transaction History
View history of all your transactions and understand their impact on performance
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Money Managers
Screen money managers from public funds and ETFs managed around the world
Is Accelerate Diagnostics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Accelerate Diagnostics. If investors know Accelerate will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Accelerate Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
74.3 M
Quarterly Revenue Growth YOY
Return On Assets
The market value of Accelerate Diagnostics is measured differently than its book value, which is the value of Accelerate that is recorded on the company's balance sheet. Investors also form their own opinion of Accelerate Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Accelerate Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Accelerate Diagnostics' market value can be influenced by many factors that don't directly affect Accelerate Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Accelerate Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine Accelerate Diagnostics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Accelerate Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.